Pharmaceuticals: Asia-Pacific Industry Guide is an essential resource for top-level data and analysis covering the Asia-Pacific Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Asia-Pacific biotechnology market grew by 11.6% in 2007 to reach a value of $37,316 million.
* The Asia-Pacific generics market generated total revenues of $32.7 billion in 2007, representing a compound annual growth rate (CAGR) of 14% for the period spanning 2003-2007.
* The Asia-Pacific OTC pharmaceuticals market generated total revenues of $39.8 billion in 2008, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2004-2008.
* The Asia-Pacific pharmaceutical market generated total revenues of $118.3 billion in 2008, representing a compound annual growth rate (CAGR) of 6.6% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN ASIA-PACIFIC 9
1.1 Market Overview 9
1.2 Market Value 11
1.3 Market Segmentation I 12
1.4 Market Segmentation II 13
1.5 Five Forces Analysis 14
1.6 Market Forecasts 20
CHAPTER 2 GENERICS IN ASIA-PACIFIC 21
2.1 Market Overview 21
2.2 Market Value 23
2.3 Market Segmentation I 24
2.4 Market Segmentation II 25
2.5 Five Forces Analysis 26
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN ASIA-PACIFIC 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 48
3.8 Market Forecasts 49
CHAPTER 4 PHARMACEUTICALS IN ASIA-PACIFIC 50
4.1 Market Overview 50
4.2 Market Value 52
4.3 Market Segmentation I 53
4.4 Market Segmentation II 54
4.5 Market Share 55
4.6 Five Forces Analysis 56
4.7 Market Forecasts 64
CHAPTER 5 APPENDIX 65
5.1 Data Research Methodology 65
LIST OF TABLES
Table 1: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007 11
Table 2: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2007 12
Table 3: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2007 13
Table 4: Asia-Pacific Biotechnology Market Value Forecast: $ million, 2007-2012 20
Table 5: Asia-Pacific Generics Market Value: $ billion, 2003-2007 23
Table 6: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2007 24
Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2007 25
Table 8: Asia-Pacific Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Table 10: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Table 14: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Table 15: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007 52
Table 16: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Table 17: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Table 18: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007 55
Table 19: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012 64
LIST OF FIGURES
Figure 1: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007 11
Figure 2: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2007 12
Figure 3: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2007 13
Figure 4: Forces Driving Competition in the Biotechnology Market in Asia-Pacific, 2007 14
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Asia-Pacific, 2007 15
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Asia-Pacific, 2007 16
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Asia-Pacific, 2007 17
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Asia-Pacific, 2007 18
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Asia-Pacific, 2007 19
Figure 10: Asia-Pacific Biotechnology Market Value Forecast: $ million, 2007-2012 20
Figure 11: Asia-Pacific Generics Market Value: $ billion, 2003-2007 23
Figure 12: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2007 24
Figure 13: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2007 25
Figure 14: Forces Driving Competition in the Generics Market in Asia-Pacific, 2007 26
Figure 15: Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2007 28
Figure 16: Drivers of Supplier Power in the Generics Market in Asia-Pacific, 2007 29
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Asia-Pacific, 2007 30
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Asia-Pacific, 2007 33
Figure 20: Asia-Pacific Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Figure 22: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Asia-Pacific 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Asia-Pacific 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Asia-Pacific 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Asia-Pacific 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Asia-Pacific 46
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Asia-Pacific 47
Figure 31: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Figure 32: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Figure 33: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007 52
Figure 34: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Figure 35: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Figure 36: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007 55
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Asia-Pacific, 2007 56
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Asia-Pacific, 2007 58
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Asia-Pacific, 2007 59
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Asia-Pacific, 2007 61
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Asia-Pacific, 2007 62
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Asia-Pacific, 2007 63
Figure 43: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012 64
Other selected research from the 'Markets' category:
Asian Medical Tourism Analysis (2008-2012)
Stakeholder Insight: Lung Cancer - Third-Generation Cytotoxics Set to Dominate the Market